美女高潮喷水白浆后入在线观看_出a级黑粗大硬长爽猛视频_qvod日韩伦理电影_亚洲自偷自拍三级_成人黄片视频_精品综合无码在线观看_亚洲综合无码中文字幕伊人_亚洲男人天堂最新版_夫洗澡公强我了60分钟_免费看又爽又黄又猛的视频

血管內(nèi)皮生長因子C(VEGFC)單克隆抗體

Monoclonal Antibody to Vascular Endothelial Growth Factor C (VEGFC)

VEGF-C; Flt4-L; VRPL; Vascular Endothelial Growth Factor-Related Protein

  • 血管內(nèi)皮生長因子C(VEGFC)單克隆抗體 產(chǎn)品包裝(模擬)
  • 血管內(nèi)皮生長因子C(VEGFC)單克隆抗體 產(chǎn)品包裝(模擬)
  • 血管內(nèi)皮生長因子C(VEGFC)單克隆抗體 DAB staining on IHC-P; Sample: Human Colorectal cancer Tissue; Primary Ab: 20μg/ml Mouse Anti-Human VEGFC Antibody Second Ab: 2μg/mL?HRP-Linked Caprine Anti-Mouse IgG Polyclonal Antibody (Catalog: SAA544Mu19)
  • 血管內(nèi)皮生長因子C(VEGFC)單克隆抗體 DAB staining on IHC-P;
    Sample: Human Lung cancer Tissue;
    Primary Ab: 20μg/ml Mouse Anti-Human VEGFC Antibody
    Second Ab: 2μg/mL?HRP-Linked Caprine Anti-Mouse IgG Polyclonal Antibody
    (Catalog: SAA544Mu19)
  • Certificate 通過ISO 9001、ISO 13485質(zhì)量體系認證

特異性

該抗體是針對VEGFC的小鼠單克隆抗體。在免疫組織化學染色和免疫印跡實驗中能識別VEGFC。

用法

Western blottin:g: 0.5-2μg/mL;
Immunohistochemistry: 5-20μg/mL;
Immunocytochemistry: 5-20μg/mL;
Optimal working dilutions must be determined by end user.

儲存

經(jīng)常使用則4°C保存。-20°C保存不超過兩年。避免反復凍融。

穩(wěn)定性

熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗決定，具體方法如下：在37°C孵育48小時，沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi)，在適當?shù)臈l件下存儲，損失率低于5%。

贈品

相關產(chǎn)品

編號 適用物種：Homo sapiens (Human，人) 應用(僅供研究使用，不用于臨床診斷！)
UAPA145Hu61 血管內(nèi)皮生長因子C(VEGFC)活性蛋白 Cell?culture;?Activity?Assays.
URPA145Hu01 血管內(nèi)皮生長因子C(VEGFC)重組蛋白 Positive Control; Immunogen; SDS-PAGE; WB.
URPA145Hu02 血管內(nèi)皮生長因子C(VEGFC)重組蛋白 Positive Control; Immunogen; SDS-PAGE; WB.
UEPA145Hu62 血管內(nèi)皮生長因子C(VEGFC)真核蛋白 Positive Control; Immunogen; SDS-PAGE; WB.
UEPA145Hu63 血管內(nèi)皮生長因子C(VEGFC)真核蛋白 Positive Control; Immunogen; SDS-PAGE; WB.
UEPA145Hu61 血管內(nèi)皮生長因子C(VEGFC)真核蛋白 Positive Control; Immunogen; SDS-PAGE; WB.
UAPA145Hu01 血管內(nèi)皮生長因子C(VEGFC)活性蛋白 Cell?culture;?Activity?Assays.
UPAA145Hu01 血管內(nèi)皮生長因子C(VEGFC)多克隆抗體 WB.
UMAA145Hu23 血管內(nèi)皮生長因子C(VEGFC)單克隆抗體 IHC
UMAA145Hu24 血管內(nèi)皮生長因子C(VEGFC)單克隆抗體 IHC
UMAA145Hu22 血管內(nèi)皮生長因子C(VEGFC)單克隆抗體 IHC
UMAA145Hu21 血管內(nèi)皮生長因子C(VEGFC)單克隆抗體 IHC
UMEA145Hu 血管內(nèi)皮生長因子C(VEGFC)檢測試劑盒(酶聯(lián)免疫吸附試驗法,小樣本) Enzyme-linked immunosorbent assay for Antigen Detection.
USEA145Hu 血管內(nèi)皮生長因子C(VEGFC)檢測試劑盒(酶聯(lián)免疫吸附試驗法) Enzyme-linked immunosorbent assay for Antigen Detection.
USCA145Hu 血管內(nèi)皮生長因子C(VEGFC)檢測試劑盒(化學發(fā)光免疫分析法) Chemiluminescent immunoassay for Antigen Detection.
ULMA145Hu 血管內(nèi)皮生長因子C(VEGFC)等多因子檢測試劑盒(流式熒光發(fā)光法) FLIA Kit for Antigen Detection.
UKSA145Hu01 血管內(nèi)皮生長因子C(VEGFC)檢測試劑盒DIY材料(酶聯(lián)免疫吸附試驗法) Main materials for "Do It (ELISA Kit) Yourself".

參考文獻

雜志 參考文獻
Journal of Cellular Biochemistry Alternatively activated RAW264. 7 macrophages enhance tumor lymphangiogenesis in mouse lung adenocarcinoma [PubMed: 19241443]
genetics and molecular research Expression of COX-2 and VEGF-C in cholangiocarcinomas at different clinical and pathological stages [PubMed: 26125824]
Experimental and Therapeutic Fenofibrate inhibits the expression of VEGFC and VEGFR-3 in retinal pigmental epithelial cells exposed to hypoxia [PubMed: 26622498]
Am J Pathol IL-10 Indirectly Regulates Corneal Lymphangiogenesis and Resolution of Inflammation via Macrophages [PubMed: 26608451]
PLoS One. Interleukin-6 Induces Vascular Endothelial Growth Factor-C Expression via Src-FAK-STAT3 Signaling in Lymphatic Endothelial Cells. [pubmed:27383632]
Oncology?Letters RNAi-mediated?gene?silencing?of?vascular?endothelial?growth?factor?C?suppresses?growth?andinduces?apoptosis?in?mouse?breast?cancer?in?vitro?and in?vivo. [pubmed:27895746]
Angiogenesis Characterization of isolated liver sinusoidal endothelial cells for liver bioengineering [Pubmed:29582235]
Oncology Reports Effects of diphyllin as a novel V-ATPase inhibitor on TE-1 and ECA-109 cells [Pubmed:29328465]
LABORATORY INVESTIGATION Dynamic signature of lymphangiogenesis during acute kidney injury and chronic kidney disease [Pubmed: 31019289]
Cutaneous and Ocular Toxicology Isotretinoin does not alter VEGF-A and VEGF-C levels: Do retinoids behave differently in dose-dependent and/or in vivo/in vitro conditions? [Pubmed: 32722957]
留言咨詢